This is in agreement with the marked reduction in the circulating levels of NEFA, resistin and leptin observed in RNAi treated rats, whose high levels were positively correlated with adiposity, insulin resistance, diabetes and metabolic syndrome39,40. The gene discussed is RETN; the disease is diabetes mellitus.